An impact analysis of the implementation of health technology assessment for new treatment of orphan diseases in Japan
An impact analysis of the implementation of health technology assessment for new treatment of orphan diseases in Japan is a paper indexed in PICO Portal from OpenAlex.
How many citations does An impact analysis of the implementation of health technology assessment for new treatment of orphan diseases in Japan have?
An impact analysis of the implementation of health technology assessment for new treatment of orphan diseases in Japan has 8 citations in the OpenAlex counts PICO Portal stores.
When was An impact analysis of the implementation of health technology assessment for new treatment of orphan diseases in Japan published?
An impact analysis of the implementation of health technology assessment for new treatment of orphan diseases in Japan has 2019 year in the PICO Portal index.
What is the open-access status of An impact analysis of the implementation of health technology assessment for new treatment of orphan diseases in Japan?
An impact analysis of the implementation of health technology assessment for new treatment of orphan diseases in Japan has closed oa status in the PICO Portal index.
What is the DOI of An impact analysis of the implementation of health technology assessment for new treatment of orphan diseases in Japan?
The DOI for An impact analysis of the implementation of health technology assessment for new treatment of orphan diseases in Japan is on the source record.
What is the PMID of An impact analysis of the implementation of health technology assessment for new treatment of orphan diseases in Japan?
The PMID for An impact analysis of the implementation of health technology assessment for new treatment of orphan diseases in Japan is on the source record.
What is the OpenAlex record for An impact analysis of the implementation of health technology assessment for new treatment of orphan diseases in Japan?
The OpenAlex for An impact analysis of the implementation of health technology assessment for new treatment of orphan diseases in Japan is on the source record.